Cargando…

Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer and is susceptible to develop gemcitabine (GEM) resistance. Decreased expression of human equilibrative nucleoside transporter 1 (hENT1) accompanied by compensatory increase of glycolysis is strongly associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Yue, Li, Ting, Xi, Yun, Zeng, Xinyi, Miao, Ying, Guo, Rui, Zhang, Min, Li, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438150/ https://www.ncbi.nlm.nih.gov/pubmed/36050724 http://dx.doi.org/10.1186/s12935-022-02681-0

Ejemplares similares

Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

ET-7 Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status
por: Raffenne, Jerome, et al.
Publicado: (2019)

Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression
por: Guo, Zhongyi, et al.
Publicado: (2018)

hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients
por: Meijer, Laura L., et al.
Publicado: (2016)

hENT1’s role in adjuvant intra-arterial gemcitabine-based chemotherapy for resectable pancreatic cancer patients
por: Wang, Wei, et al.
Publicado: (2023)

hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
por: Aughton, Karen, et al.
Publicado: (2021)

Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer
por: Kim, Jaihwan, et al.
Publicado: (2018)

Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer
por: Elander, N. O., et al.
Publicado: (2018)

MiR-33a functions as a tumor suppressor in triple-negative breast cancer by targeting EZH2
por: Weihua, Zeng, et al.
Publicado: (2020)

LRP11-AS1 promotes the proliferation and migration of triple negative breast cancer cells via the miR-149-3p/NRP2 axis
por: Li, Peng, et al.
Publicado: (2022)

Decreased erythrocyte nucleoside transport and hENT1 transporter expression in glucose 6-phosphate dehydrogenase deficiency
por: Al-Ansari, Mohammad, et al.
Publicado: (2015)

Human Equilibrative Nucleoside Transporter 1 (hENT1) in Pancreatic Adenocarcinoma: Towards Individualized Treatment Decisions
por: Spratlin, Jennifer L., et al.
Publicado: (2010)

MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression
por: Yang, Zhi-Xue, et al.
Publicado: (2018)

A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine
por: Kalloger, Steve E, et al.
Publicado: (2017)

LINC00514 upregulates CCDC71L to promote cell proliferation, migration and invasion in triple‐negative breast cancer by sponging miR-6504-5p and miR-3139
por: Luo, Xiao, et al.
Publicado: (2021)

SNP rs3202538 in 3′UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population
por: Shi, Yaxiang, et al.
Publicado: (2017)

Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study
por: Boyd, Lenka N. C., et al.
Publicado: (2023)

A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression
por: Luo, Lingli, et al.
Publicado: (2020)

Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer
por: Elebro, Jacob, et al.
Publicado: (2016)

SKM-1细胞地西他滨耐药机制中hENT1功能的研究
Publicado: (2015)

Bidirectional transport of 2-chloroadenosine by equilibrative nucleoside transporter 4 (hENT4): Evidence for allosteric kinetics at acidic pH
por: Tandio, David, et al.
Publicado: (2019)

Gestational Diabetes—Placental Expression of Human Equilibrative Nucleoside Transporter 1 (hENT1): Is Delayed Villous Maturation an Adaptive Pattern?
por: Giacometti, Cinzia, et al.
Publicado: (2023)

Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3
por: Fang, Xuan, et al.
Publicado: (2020)

Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis
por: Chen, Fei-Yu, et al.
Publicado: (2020)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)

The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease
por: Vacante, Francesca, et al.
Publicado: (2019)

Are ENT1/ENT1, NOTCH3, and miR-21 Reliable Prognostic Biomarkers in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Gemcitabine Monotherapy?
por: Jiraskova, Lucie, et al.
Publicado: (2019)

Study of miR-143 expression in stomach cancer
por: Huang, Shao-Jun, et al.
Publicado: (2018)

MiR-369-3p participates in endometrioid adenocarcinoma via the regulation of autophagy
por: Liu, Ping, et al.
Publicado: (2019)

The role of miR-485-5p/NUDT1 axis in gastric cancer
por: Duan, Jingjing, et al.
Publicado: (2017)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
por: He, Zhixian, et al.
Publicado: (2018)

Involvement of Dual Strands of miR-143 (miR-143-5p and miR-143-3p) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma
por: Sanada, Hiroki, et al.
Publicado: (2019)

ZMIZ2 promotes the development of triple-receptor negative breast cancer
por: Zou, Xiaopan, et al.
Publicado: (2022)

[Retracted] Study of miR-143 expression in stomach cancer
por: Huang, Shao-Jun, et al.
Publicado: (2023)

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer
por: Lv, Xuemei, et al.
Publicado: (2019)

LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis
por: Wu, Liangcai, et al.
Publicado: (2020)

CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis
por: Dou, Dongwei, et al.
Publicado: (2020)

Associations between microRNA (miR-25, miR-32, miR-125, and miR-222) polymorphisms and recurrent implantation failure in Korean women
por: Lee, Jeong Yong, et al.
Publicado: (2019)

Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin
por: Kulsoom, Bibi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_735nrava3m7nl188n2pp8hhq87